Affiliation:
1. National Medical Research Center for Therapy and Preventive Medicine
2. National Center for Cardiology and Therapy named after Academician M. Mirrakhimov
3. National Medical Research Center for Therapy and Preventive Medicine; Lomonosov Moscow State University
4. Kyrgyz Russian Slavic University named after the First President of Russia B. N. Yeltsin
5. National Medical Research Center for Therapy and Preventive Medicine
Abstract
Objective. To assess the distribution of cardiac troponin I (cTnI) in a sample of the Kyrgyz Republic population, to study its associations with risk factors and to identify the possible ethnic differences. Design and methods. This observational cross-sectional study includes a representative sample of the Kyrgyz Republic population aged 20–64 years (n = 1256). The analysis of cTnI levels in the population and associations of cTnI levels with socio-demographic parameters (sex, age, education, etc.), risk factors (smoking, obesity, hypertension, etc.), blood biochemical parameters (triglycerides, lipid profile, glucose) and an anamnesis of cardiovascular diseases and total cardiovascular risk according to the SCORE scale. The statistical significance level was considered equal to 0,05. Results. The median cTnI level in the Kyrgyz sample was 0,90 pg/ml [0,40; 1,80]. The 99th percentile for the entire sample was 21,4 pg/ml in men and 12,2 pg/ml in women. The median cTnI in the Slavs sample was 1,40 pg/ml [0,60; 2,20]. The 99th percentile for the entire sample was 21,2 pg/ml in men and 25,2 pg/ml in women. The cTnI level log increases significantly with age in both men and women. At the age of 20-30 years, the cTnI level in men is higher than in women in both ethnic groups. However, with age, the increase rate of cTnI in women is higher than in men in both ethnic groups. In a multivariate analysis, significant associations of cTnI levels with sex, age, hypertension, stroke, blood levels of total cholesterol and triglycerides were obtained. Insufficient accuracy of classification of study participants by SCORE risk was revealed. Conclusions. cTnI is a potential strong biomarker that complements traditional risk scales and is applicable in the framework of cardiovascular diseases primary prevention strategies, which was confirmed in this study on the Kyrgyz Republic population.
Publisher
Arterialnaya Gipertenziya
Subject
Cardiology and Cardiovascular Medicine,Internal Medicine
Reference23 articles.
1. World Heart Organization fact sheets: cardiovascular disease [cited 2022 Dec 9]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/cardiovasculardiseases-(cvds)
2. Republican Medical Information Center [cited 2022 Dec 9]. Available from: http://cez.med.kg
3. Gerszten RE, Wang TJ. The search for new cardiovascular biomarkers. Nature. 2008 Feb 21;451(7181):949-52. doi: 10.1038/nature06802
4. Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA. 2003 Aug 20;290(7):898-904. doi:10.1001/jama.290.7.898
5. Thygesen K, Alpert JS, Jaffe AS, Chaitmanet BR, Bax JJ, Morrow DA et al. ESC Scientific Document Group. Fourth universal definition of myocardial infarction (2018). Eur Heart J 2019;40:237–269. doi:10.1093/eurheartj/ehy462